Sanofi SA
LSE:0A2V
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sanofi SA
LSE:0A2V
|
FR |
|
N
|
Novartis AG
SWB:NOT
|
CH |
|
NIB Holdings Ltd
ASX:NHF
|
AU |
|
Magellan Aerospace Corp
TSX:MAL
|
CA |
|
N
|
Norfolk Southern Corp
XMUN:NFS
|
US |
|
D
|
Direct Line Insurance Group PLC
SWB:D1LN
|
UK |
|
G
|
Giglio.Com SpA
MIL:GCOM
|
IT |
|
B
|
Bombardier Inc
OTC:BDRAF
|
CA |
|
Integrated Industries Ltd
BSE:531889
|
IN |
|
China Resources Cement Holdings Ltd
F:C44
|
HK |
|
W
|
Willis Towers Watson PLC
NASDAQ:WTW
|
UK |
|
G
|
Genesis AI Corp
CNSX:AIG
|
CA |
|
Nippon Sanso Holdings Corp
TSE:4091
|
JP |
|
Talen Energy Corp
NASDAQ:TLN
|
US |
|
B
|
Bakrie & Brothers Tbk PT
XMUN:LFU2
|
ID |
|
EVE Energy Co Ltd
SZSE:300014
|
CN |
|
Tristate Holdings Ltd
HKEX:458
|
HK |
Wall St Price Targets
0A2V Price Targets Summary
Sanofi SA
According to Wall Street analysts, the average 1-year price target for
0A2V is 55.9868 USD with a low forecast of 33.1536 USD and a high forecast of 67.7237 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0A2V's stock price target?
Price Target
55.9868
USD
According to Wall Street analysts, the average 1-year price target for
0A2V is 55.9868 USD with a low forecast of 33.1536 USD and a high forecast of 67.7237 USD.